Annual Long Term Debt
$0.00
-$357.00 K-100.00%
31 December 2023
Summary:
Astria Therapeutics annual long term debt is currently $0.00, with the most recent change of -$357.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$397.00 thousand (-100.00%). ATXS annual long term debt is now -100.00% below its all-time high of $5.72 million, reached on 31 December 2015.ATXS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$4.26 M
-$283.00 K-6.23%
30 September 2024
Summary:
Astria Therapeutics quarterly long term debt is currently $4.26 million, with the most recent change of -$283.00 thousand (-6.23%) on 30 September 2024. Over the past year, it has increased by +$4.26 million (+100.00%). ATXS quarterly long term debt is now -47.72% below its all-time high of $8.15 million, reached on 31 March 2015.ATXS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXS Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -100.0% | +100.0% |
3 y3 years | -100.0% | +100.0% |
5 y5 years | 0.0% | - |
ATXS Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -100.0% | -6.2% | ||
5 y | 5 years | -100.0% | -6.2% | ||
alltime | all time | -100.0% | -47.7% |
Astria Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $4.26 M(-6.2%) |
June 2024 | - | $4.54 M(>+9900.0%) |
Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2023 | - | $0.00(-100.0%) |
June 2023 | - | $53.00 K(-74.4%) |
Mar 2023 | - | $207.00 K(-42.0%) |
Dec 2022 | $357.00 K(>+9900.0%) | $357.00 K(-29.2%) |
Sept 2022 | - | $504.00 K(-22.3%) |
June 2022 | - | $649.00 K(>+9900.0%) |
Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2021 | - | $0.00(-100.0%) |
June 2021 | - | $58.00 K(-74.7%) |
Mar 2021 | - | $229.00 K(-42.3%) |
Dec 2020 | $397.00 K | $397.00 K(-29.0%) |
Sept 2020 | - | $559.00 K(-22.1%) |
Date | Annual | Quarterly |
---|---|---|
June 2020 | - | $718.00 K(-17.9%) |
Mar 2020 | - | $875.00 K(-14.9%) |
Dec 2019 | $1.03 M(>+9900.0%) | $1.03 M(+211.5%) |
Mar 2019 | - | $330.00 K(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
June 2017 | - | $831.00 K(-49.8%) |
Mar 2017 | - | $1.66 M(-33.2%) |
Dec 2016 | $2.48 M(-56.7%) | $2.48 M(-24.8%) |
Sept 2016 | - | $3.30 M(-19.8%) |
June 2016 | - | $4.11 M(-16.4%) |
Mar 2016 | - | $4.92 M(-14.0%) |
Dec 2015 | $5.72 M(+28.9%) | $5.72 M(-12.7%) |
Sept 2015 | - | $6.55 M(-10.9%) |
June 2015 | - | $7.35 M(-9.8%) |
Mar 2015 | - | $8.15 M(+83.6%) |
Dec 2014 | $4.44 M | $4.44 M |
FAQ
- What is Astria Therapeutics annual long term debt?
- What is the all time high annual long term debt for Astria Therapeutics?
- What is Astria Therapeutics annual long term debt year-on-year change?
- What is Astria Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Astria Therapeutics?
- What is Astria Therapeutics quarterly long term debt year-on-year change?
What is Astria Therapeutics annual long term debt?
The current annual long term debt of ATXS is $0.00
What is the all time high annual long term debt for Astria Therapeutics?
Astria Therapeutics all-time high annual long term debt is $5.72 M
What is Astria Therapeutics annual long term debt year-on-year change?
Over the past year, ATXS annual long term debt has changed by -$357.00 K (-100.00%)
What is Astria Therapeutics quarterly long term debt?
The current quarterly long term debt of ATXS is $4.26 M
What is the all time high quarterly long term debt for Astria Therapeutics?
Astria Therapeutics all-time high quarterly long term debt is $8.15 M
What is Astria Therapeutics quarterly long term debt year-on-year change?
Over the past year, ATXS quarterly long term debt has changed by +$4.26 M (+100.00%)